US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 6.160
  • -0.060-0.96%
Close Apr 26 16:00 ET
  • 6.330
  • +0.170+2.76%
Post 18:48 ET
516.96MMarket Cap-1974P/E (TTM)

Verve Therapeutics Key Stats

Verve Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

5.14M

+408.30%
EPS(YoY)

-0.69

-2.99%

Strong Buy

Apr 8, 2024

Verve Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 2.639M--
--2024/Q1-- / 2.250M--
--2023/Q45.143M / 1.167M--
--2023/Q33.117M / 1.084M--
--2023/Q22.093M / 672.670K--
May 15, 20232023/Q11.404M / 514.290K--
--2022/Q41.012M / 442.860K--
--2022/Q3929.000K / 833.330K--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 2.639M--
--2024/Q1-- / 2.250M--
--2023/Q45.143M / 1.167M--
--2023/Q33.117M / 1.084M--
--2023/Q22.093M / 672.670K--
May 15, 20232023/Q11.404M / 514.290K--
--2022/Q41.012M / 442.860K--
--2022/Q3929.000K / 833.330K--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Verve Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 8, 2024

Strong Buy

  • Buy

    85.71%
  • Hold

    14.29%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg